Analysis of the Impact of Commercialized Hybrid Closed-Loop System on Glycemic Control, Glycemic Variability, and Patient-Related Outcomes in Children and Adults: A Focus on Superiority Over Predictive Low-Glucose Suspend Technology [published online ahead of print, 2020 Aug 28]. Diabetes Technol Ther. 2020;10.1089/dia.2019.0400. doi:10.1089/dia.2019.0400.F.I.:4.392

Inicio Repositorio Analysis of the Impact of Commercialized Hybrid Closed-Loop System on Glycemic Control, Glycemic Variability, and Patient-Related Outcomes in Children and Adults: A Focus on Superiority Over Predictive Low-Glucose Suspend Technology [published online ahead of print, 2020 Aug 28]. Diabetes Technol Ther. 2020;10.1089/dia.2019.0400. doi:10.1089/dia.2019.0400.F.I.:4.392

2020/08

Autores/as:

Beato-Víbora PI, Gallego-Gamero F, Lázaro-Martín L, Romero-Pérez MDM, Arroyo-Díez FJ.

Servicio:

Endocrinología y Nurición.- . Hospital Universitario de Badajoz

Tipo:

Artículo

Materia:

{«label»:»Resumen Pubmed»,»link»:»https://pubmed.ncbi.nlm.nih.gov/31855446/»}

info@areasaludbadajoz.com

Contacto

Salud

Información

Ciudadanos

info@areasaludbadajoz.com

Contacto

Salud​

Información​

Ciudadanos​

Salud

Información

Ciudadanos